Review : Molecular Design of Methotrexate-Antibody Conjugates for Targeted Cancer Treatment

Abstract

Keywords

antibody conjugates targeted delivery methotrexate tumor targeting monoclonal Ab selective cytotoxicity.

Get full access to this article

View all access options for this article.

References

Boyer, C.M. , Y. Lidor , S.C. Lottich and R.C. Bast, Jr. 1988. "Antigenic Cell Surface Markers in Human Solid Tumors ," Antibody, Immunoconjugates, and Radiopharmaceuticals, 1:105-162.

Sell, S. 1990. "Cancer Markers of the 1990s. Comparison of the New Generation of Markers Defined by Monoclonal Antibodies and Oncogene Probes to Prototypic Markers," Clin. Lab. Med., 10:1-37.

Blair, A.H. and T.I. Ghose. 1983. "Linkage of Cytotoxic Agents to Immunoglobulins ," J. Immunol. Methods, 59:129-143.

Hara, T. and Y. Kato. 1988. "Antibody-Cytotoxic Agent Conjugates for Cancer Targeting Therapy," J. Synth. Org Chem. (Tokyo) , 46:1106-1115.

Pimm, M.V. 1988. "Drug-Monoclonal Antibody Conjugates for Cancer Therapy: Potentials and Limitations," Crit. Rev. Ther. Drug Carrier Syst., 5:189-227.

Koppel, G.A. 1990. "Recent Advances with Monoclonal Antibody Drug Targeting for the Treatment of Human Cancer," Bioconjugate Chem., 1:13-23.

Smyth, M.J. , G.A. Pietersz , B.J. Classon and I.F.C. McKenzie . 1986. "Specific Targeting of Chlorambucil to Tumors with the Use of Monoclonal Antibodies," Int. Natl. J. Cancer, 76:503-510.

Biddle, W.C. , Y. Haruta , B.K. Seon , E.S. Henderson and E.J. Sarcione. 1989. "In Vitro and In Vivo Cytotoxic Activity of Anti-Human Leukemia Monoclonal Antibodies SN5c and SN6 Daunorubicin Conjugates ," Leukemia Res., 13:699-707.

Aboud-Pirak, E. , E. Hurwitz , F. Bellot , J. Schlessinger and M. Sela. 1989. " Inhibition of Human Tumor Growth in Nude Mice by a Conjugate of Doxorubicin with Monoclonal Antibodies to Epidermal Growth Factor Receptor," Proc. Natl. Acad. Sci. U.S.A., 86:3778-3781.

10.

Umemoto, N. , Y. Kato , Y. Takeda , M. Saito , T. Hara , M. Seto and T. Takahashi. 1984. "Conjugates of Mitomycin C with the Immunoglobulin M Monomer Fragment of a Monoclonal Anti-MM46 Immunoglobulin M Antibody with or without Serum Albumin as Intermediary," J. Appl. Biochem., 6:297-307.

11.

Hashimoto, Y. , M. Sugawara , T. Masuko and H. Hojo. 1983. "Antitumor Effect of Actinomycin D Entrapped in Liposomes Bearing Subunits of Tumor-Specific Monoclonal Immunoglobulin M Antibody," Cancer Res., 43:5328-5334.

12.

Luders, G. , W. Kohnlein , C. Sorg and J. Bruggen. 1985. "Selective Toxicity of Neocarzinostatin-Monoclonal Antibody Conjugates to the Antigen-Bearing Human Melanoma Cell Line In Vitro," Cancer Immunol. Immunother., 20:85-90.

13.

Aboud-Pirak, E. , B. Lesur , K.S.P.B. Rao , R. Baurain , A. Trouet and Y.-J. Schneider. 1989. "Cytotoxic Activity of Daunorubicin or Vindesin Conjugated to a Monoclonal Antibody on Cultured MCF-7 Breast Carcinoma Cells," Biochem. Pharmacol., 38:641-648.

14.

Johnson, I.S. , M.E. Spearman , G.C. Todd , J.L. Zimmerman and T.F. Bumol. 1987. " Monoclonal Antibody Drug Conjugates for Site-Directed Cancer Chemotherapy: Preclinical Pharmacology and Toxicology Studies," Cancer Treatment Rev., 14:193-196.

15.

Embleton, M.J. and M.C. Garnett. 1985. "Antibody Targeting of AntiCancer Agents," in Monoclonal Antibodies for Cancer Detection and Therapy, R. W Baldwin and V. S. Byers , eds., London : Academic Press Inc., pp. 317-344.

16.

Nalpern, S.E. , P.L. Hagan , P.R. Garver , J.A. Koziol , A.W.N. Chen , J.M. Frincke , R.M. Bartholomew , G.S. David and T.H. Adams. 1983. "Stability, Characterization, and Kinetics of 111In-Labeled Monoclonal Antitumor Antibodies in Normal Animals and Nude Mouse-Human Tumor Models," Cancer Res., 43:5347-5355.

17.

Huennekens, F.M. , T.H. Duffy , L.E. Pope , G.C. Grundler , J.K. Sato and K.S. Vitols. 1987. "Biochemistry of Methotrexate: Teaching an Old Drug New Tricks," in Cancer Biology and Therapeutics , J. G. Cory and A. Szentivanyi , eds., NY: Plenum Publishing Co., pp. 43-61.

18.

Trouet, A. , D. Deprez-De Campeneere and C. De-Duve. 1972. "Chemotherapy through Lysosomes with a DNA-Daunorubicin Complex," Nature (London) New Biol ., 239:110-112.

19.

Mathe, G. , T.B. Loc and J. Bernard. 1958. "Effect sur la leucemie 1210 de la souris d'une combinaison par diazotation d'A-methopterine et de γ-globulines de hamsters porteurs de cette leucemie par heterogreffe," C. R. Acad. Sci., 246:1626-1628.

20.

DeCarvalho, S. , H.J. Rand and A. Lewis. 1964. "Coupling of Cyclic Chemotherapeutic Compounds to Immune Gamma-Globulins," Nature , 202:255-258.

21.

Calendi, E. , G. Costanzi , F. Indiveri , G. Lotti and C. Zini. 1969. "Histoimmunologic Specificity of an Anti-Limphoid Tissue Sarcoma γ-Globulin Bound to Methotrexate," Boll. Chim. Farm., 108:25-28.

22.

Robinson, D.A. , J.M. Whiteley and N.G.L. Harding. 1973. " Cell-Directed Antimetabolites: Alternative Syntheses of Cytotoxic Methotrexate-Containing Macromolecules," Biochemical Society Transactions, 1:722-726.

23.

Elias, D.J. , L. Hirschowitz , L.E. Kline , J.F. Kroener , R.O. Dillman , L.E. Walker , J.A. Robb and R.M. Timms. 1990. "Phase I Clinical Comparative Study of Monoclonal Antibody KS1/4 and KS1/4-Methotrexate Immunoconjugate in Patients with Non-Small Cell Lung Carcinoma," Cancer Res. , 50:4154-4159.

24.

Burstein, S. 1977. "Chemotherapy of Murine Ovarian Carcinoma by Methotrexate-Antibody Conjugates," J. Med. Chem. , 20:950-952.

25.

Latif, Z.A. , B.B. Lozzio , C.J. Wust , S. Krauss , M.C. Aggio and C.B. Lozzio. 1980. "Evaluation of Drug-Antibody Conjugates in the Treatment of Human Myelosarcomas Transplanted in Nude Mice ," Cancer, 45:1326-1333.

26.

Kulkarni, P.N. , A.H. Blair and T.I. Ghose. 1981. "Covalent Binding of Methotrexate to Immunoglobulins and the Effect of Antibody-Linked Drug on Tumor Growth In Vivo," Cancer Res., 41:2700-2706.

27.

Ghosh, M.K. , D.O. Kildsig and A.K. Mitra. 1989. "Preparation and Characterization of Methotrexate-Immunoglobulin Conjugates," Drug Design and Delivery, 4:13-25.

28.

Vadia, P. , A.H. Blair and T. Ghose. 1983. "Uptake of Methotrexate Linked to an Anti-EL4-Lymphoma Antibody by EL4 Cells," Cancer Immunol. Immunother., 16:127-129.

29.

Vadia, P. , A.H. Blair and T. Ghose. 1984. "Tumor and Tissue Distribution of a Methotrexate-Anti-EL4 Immunoglobulin Conjugate in EL4 Lymphoma-Bearing Mice ," Cancer Res., 44:4263-4266.

30.

Kulkarni, P.N. , A.H. Blair , T. Ghose and M. Mammen. 1985. "Conjugation of Methotrexate to IgG Antibodies and Their F(ab')2 Fragments and the Effect of Conjugated Methotrexate on Tumor Growth In Vivo," Cancer Immunol. Immunother., 19:211-214.

31.

Vadia, P. , A.H. Blair , T. Ghose and S. Ferrone. 1985. "Uptake of Methotrexate Linked to Polyclonal and Monoclonal Antimelanoma Antibodies by a Human Melanoma Cell Line," J. Natl. Cancer Inst., 74:29-35.

32.

Kannelos, J. , G.A. Pietersz and I.F.C. McKenzie . 1985. "Studies of Methotrexate-Monoclonal Antibody Conjugates for Immunotherapy," J. Natl. Cancer Inst. , 75:319-332.

33.

Smyth, M.J. , G.A. Pietersz and I.F.C. McKenzie. 1987. " The Mode of Action of Methotrexate-Monoclonal Antibody Conjugates," Immunol. Cell Biol., 65:(Pt. 2), 189-200.

34.

Kanellos, J. , G.A. Pietersz , Z. Cunningham and I.F.C. McKenzie. 1987. " Anti-Tumour Activity of Aminopterin-Monoclonal Antibody Conjugates; In Vitro and In Vivo Comparison with Methotrexate-Monoclonal Antibody Conjugates," Immunol. Cell Biol., 65:(Pt. 6), 483-493.

35.

Pietersz, G.A. , M.J. Smyth , J. Kenellos , Z. Cunningham , N.P.M. Sacks and I.F.C. McKenzie. 1988. "Preclinical and Clinical Studies with a Variety of Immunoconjugates ," Antibody, Immunoconjugates, and Radiopharmaceuticals, 1:79-103.

36.

Durrant, L.G. , M.C. Garnett , J. Gallego , N.C. Armitage , K.C. Ballantyne , P.A. Marksman , J.D. Hardcastle and R.W. Baldwin. 1987. " Sensitivity of Newly Established Colorectal Cell Lines to Cytotoxic Drugs and Monoclonal Antibody Drug Conjugates," Br. J. Cancer, 56:722-726.

37.

Pimm, M.V. , J.A. Clegg , M.C. Garnett and R.W. Baldwin. 1988. "Biodistribution and Tumor Localization of a Methotrexate-Monoclonal-Antibody 791T/36 Conjugate in Nude Mice with Human Tumor Xenografts," Int. J. Cancer, 41:886-891.

38.

Ballantyne, K.C. , A.C. Perkins , M.V. Pimm , M.C. Garnett , J.A. Clegg , N.C. Armitage , R.W. Baldwin and J.D. Hardcastle. 1988. "Biodistribution of a Monoclonal Antibody-Methotrexate Conjugate (791T/36-MTX) in Patients with Colorectal Cancer," Int. J. Cancer (Suppl.2):103-108.

39.

Shawler, D.L. , D.E. Johnson , M.D. Sweet , L.J. Myers , S.D. Tudor , D.E. Beidler , J.A. Koziol and R.O. Dillman. 1988. "Preclinical Trials Using an Immunoconjugate of T101 and Methotrexate in an Athymic Mouse/Human T-Cell Tumor Model," J. Biol. Response Modifiers, 7:608-618.

40.

Dillman, P.O. , D.E. Johnson , J. Ogden and D. Beidler. 1989. "Significance of Antigen, Drug, and Tumor Cell Targets in the Preclinical Evaluation of Doxorubicin, Daunorubicin, Methotrexate, and Mitomycin-C Monoclonal Antibody Immunoconjugates ," Mol. Biother., 1:250-255.

41.

Deguchi, T. , T.M. Chu , S.S. Leong , J.S. Horoszewicz and C.-I. Lee. 1986. " Effect of Methotrexate-Monoclonal Anti-Prostatic Acid Phosphatase Antibody Conjugate on Human Prostate Tumor," Cancer Res., 46:3751-3755.

42.

Rowland, A.J. , M.E. Harper , D.W. Wilson and K. Griffiths. 1990. "The Effect of an Anti-Membrane Antibody-Methotrexate Conjugate on the Human Prostatic Tumor Line PC3," Br. J. Cancer, 61:702-708.

43.

Endo, N. , Y. Takeda , K. Kishida , Y. Kato , M. Saito , N. Umemoto and T. Hara. 1987. "Target-Selective Cytotoxicity of Methotrexate Conjugated with Monoclonal Anti-MM46 Antibody," Cancer Immunol. Immunother., 25:1-6.

44.

Endo, N. , Y. Takeda , N. Umemoto , K. Kishida , K. Watanabe , M. Saito , Y. Kato and T. Hara. 1988. "Nature of Linkage and Mode of Action of Methotrexate Conjugated with Antitumor Antibodies: Implications for Future Preparation of Conjugates," Cancer Res., 48:3330-3335.

45.

Kralovec, J. , G. Spencer , A.H. Blair , M. Mammen , M. Singh and T. Ghose. 1989. "Synthesis of Methotrexate-Antibody Conjugates by Regiospecific Coupling and Assessment of Drug and Antitumor Activities," J. Med. Chem., 32:2426-2431.

46.

Piper, J.R. , J.A. Montgomery , F.M. Sirotnak and P.L. Chello. 1982. "Syntheses of α- and γ-Substituted Amides, Peptides, and Esters of Methotrexate and Their Evaluation as Inhibitors of Folate Metabolism," J. Med. Chem. , 25:182-187.

47.

Baldwin, R.W. , M.J. Embleton , M.C. Garnett and M.V. Pimm. 1987. "Conjugates of Monoclonal Antibody 791T/36 with Methotrexate in Cancer Therapy," NCI Monogr., 3:95-99.

48.

Raso, V. , C. Fehrmann , V.C. Solan and A. Rosowsky. 1988. "Monensin is Obligatory for the Cytotoxic Action of a Disulfide Linked Methotrexate-Anti-Transferrin Receptor Conjugate ," Biochem. Biophys. Res. Commun., 150:104-110.

49.

Umemoto, N. , Y. Kato and T. Hara. 1989. "Cytotoxicities of Two Disulfide-Bond-Linked Conjugates of Methotrexate with Monoclonal Anti-MM46 Antibody," Cancer Immunol. Immunother., 28:9-16.

50.

Umemoto, N. , Y. Kato , N. Endo , Y. Takeda and T. Hara. 1989. "Preparation and In Vitro Cytotoxicity of a Methotrexate-Anti-MM46 Monoclonal Antibody Conjugate via an Oligopeptide Spacer," Int. J. Cancer, 43:677-684.

51.

Masuho, Y. and T. Hara. 1980. "Target-Cell Cytotoxicity of a Hybrid of Fab' of Immunoglobulin and A-Chain of Ricin," Gann (Jpn. J. Cancer Res.), 71:759-765.

52.

Trouet, A. , M. Masquelier , R. Baurain and D. Deprez-DeCampeneere . 1982. "A Covalent Linkage between Daunorubicin and Proteins that is Stable in Serum and Reversible by Lysosomal Hydrolases, as Required for a Lisosomotropic Drug-Carrier Conjugate: In Vitro and In Vivo Studies," Proc. Natl. Acad. Sci. U.S.A., 79:626-629.

53.

Lesur, B. , M. Masquelier , R. Baurain , Y.-J. Schneider and A. Trouet. 1984. "Covalent Linkage of Anthracyclines to Macromolecular Carriers," Protides Biol. Fluids, 32:437-440.

54.

Endo, N. , N. Umemoto , Y. Kato , Y. Takeda and T. Hara. 1987. "A Novel Covalent Modification of Antibodies at Their Amino Groups with Retention of Antigen-Binding Activity," J. Immunol. Methods, 104:253-258.

55.

Lopes, A.D. , R.D. Radcliffe , D.J. Coughlin , L.S. Lee , T.J. McKearn and J.D. Rodwell. 1987. "Site-Selective Methotrexate-Antibody Conjugates Yield a Superior Therapeutic Effect in Tumor Xenograft-Bearing Nude Mice," in Clinical Immunology, W Pruzanski and M. Seligmann , eds., New York: Elsevier, pp. 303-307.

56.

Kralovec, J. , M. Singh , M. Mammen , A.H. Blair and T. Ghose. 1989. "Synthesis of Site-Specific Methotrexate-IgG Conjugates. Comparison of Stability and Antitumor Activity with Active-Ester-Based Conjugates," Cancer Immunol. Immunother. , 29:293-302.

57.

Shih, L.B. , R.M. Sharkey , F.J. Primus and D.M. Goldenberg . 1988. "Site-Specific Linkage of Methotrexate to Monoclonal Antibodies Using an Intermediate Carrier," Int. J. Cancer, 41:832-839.

58.

Montgomery, J.A. and J.R. Piper. 1984. "Design and Synthesis of Folate Analogs as Antimetabolites," in Folate Antagonists as Therapeutic Agents, Vol. 1, F. M. Sirotnak , J. J. Burchall , W. B. Ensminger and J. A. Montgomery , eds., Orlando: Academic Press Inc., pp. 219-260.

59.

Garnett, M.C. , M.J. Embleton , E. Jacobs and R.W. Baldwin. 1983. "Preparation and Properties of a Drug-Carrier-Antibody Conjugate Showing Selective Antibody-Directed Cytotoxicity In Vitro," Int. J. Cancer, 31:661-670.

60.

Garnett, M.C. , E. Jacobs , M.J. Embleton and R.W. Baldwin. 1984. "Studies on the Mechanism of Action of a Drug-Carrier-Antibody Conjugate," Biochemical Society Transactions, 12:1035-1036.

61.

Baldwin, R.W. , M.J. Embleton , M.C. Garnett , M.V. Pimm , M.R. Price , N.A. Armitage , P.A. Farrands , J.D. Hardcastle , A. Perkins and G.F. Rowland. 1984. "Application of Monoclonal Antibody 791T/36 for Radioimmunodetection of Human Tumours and for Targeting Cytotoxic Drugs," Protides Biol. Fluids, 31:775-781.

62.

Embleton, M.J. , M.C. Garnett , E. Jacobs and R.W. Baldwin. 1984. "Antigenicity and Drug Susceptibility of Human Osteogenic Sarcoma Cells "Escaping" a Cytotoxic Methotrexate-Albumin-Monoclonal Antibody Conjugate," Br. J. Cancer, 49:559-565.

63.

Garnett, M.C. , M.J. Embleton , E. Jacobs and R.W. Baldwin. 1985. "Studies on the Mechanism of Action of an Antibody-Targeted Drug-Carrier Conjugate," Anti-Cancer Drug Design, 1:3-12.

64.

Embleton, M.J. , M.C. Garnett and R.W. Baldwin. 1985. "Use of an Anti-Tumour Monoclonal Antibody for Targeting Methotrexate," Protides Biol. Fluids, 32:429-431.

65.

Garnett, M.C. and R.W. Baldwin. 1986. "An Improved Synthesis of a Methotrexate-Albumin-791T/36 Monoclonal Antibody Conjugate Cytotoxic to Human Osteogenic Sarcoma Cell Lines," Cancer Res., 46:2407-2412.

66.

Affleck, K. and M.J. Embleton. 1989. "Sensitivity of a Methotrexate-Resistant-Tumour Cell Line to a Methotrexate-Albumin-Monoclonal Antibody Conjugate," Br. J. Cancer, 60:474-475.

67.

Embleton, M.J. , N.A. Habib , M.C. Garnett and C. Wood. 1986. "Unsuitability of Monoclonal Antibodies to Oncogene Proteins for Anti-Tumour Drug-Targeting," Int. J. Cancer, 38:821-827.

68.

Endo, N. , Y. Kato , Y. Takeda , M. Saito , N. Umemoto , K. Kishida and T. Hara. 1987. "In Vitro Cytotoxicity of a Human Serum Albumin-Mediated Conjugate of Methotrexate with Anti-MM46 Monoclonal Antibody ," Cancer Res., 47:1076-1080.

69.

Pietersz, G.A. , Z. Cunningham and I.F.C. McKenzie. 1988. " Specific In Vitro Anti-Tumour Activity of Methotrexate-Monoclonal Antibody Conjugates Prepared Using Human Serum Albumin as an Intermediary," Immunol. Cell Biol., 66:(Pt. 1), 43-49.

70.

Pimm, M.V. , R.A. Robins , M.J. Embleton , E. Jacobs , A.J. Markham , A. Charleston and R.W. Baldwin. 1990. "A Bispecific Monoclonal Antibody against Methotrexate and a Human Tumor Associated Antigen Augments Cytotoxicity of Methotrexate-Carrier Conjugate," Br. J. Cancer, 61: 508-513.

71.

Shen, W.-C. , B. Ballou , H.J.-P. Ryser and T.R. Hakala. 1986. "Targeting, Internalization, and Cytotoxicity of Methotrexate-Monoclonal Anti-Stage-Specific Embryonic Antigen-1 Antibody Conjugates in Cultured F-9 Teratocarcinoma Cells," Cancer Res., 46:3912-3916.

72.

Persiani, S. , B. Ballou , W.-C. Shen , H.J.-P. Ryser , J.M. Reiland and T.R. Hakala. 1989. "In Vitro Antitumor Effect of Methotrexate Conjugated to a Monoclonal IgM Antibody Specific for Stage-Specific Embryonic Antigen-1, on MH-15 Mouse Teratocarcinoma," Cancer Immunol. Immunother., 29:167-170.